GSA Capital Partners’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-22,127	Closed	-$1.12M	–	1860
2024 Q3	$1.12M	Buy	22,127 +403	+2%	+$20.3K	0.08%	406
2024 Q2	$955K	Buy	+21,724	New	+$955K	0.07%	534